Is it safe for me to exercise while having treatment?

 

Ask a Question

Q: Is it safe for me to exercise while having treatment? 

A: Your body needs exercise to combat fatigue, rest properly, increase your stamina, and maintain emotional well-being. What’s more, cancer patients who are physically active have better treatment outcomes.

It’s important to listen to your body and talk with your doctor before starting any physical activity. You may need to alter your exercise routine somewhat. If you’re not feeling up to taking a walk, you can do gentle range-of-motion movements in bed or seated exercises with bands or light weights. Rest when you need to.

Don’t exercise if you feel dizzy, experience an irregular heartbeat, or have difficulty breathing. Sometimes, mild exercise will take your mind off of nagging or persistent nausea or pain. With balance problems, avoid uneven surfaces and weight-bearing activities. Stay out of swimming pools during radiation treatment because the chlorine can cause further irritation to your skin.
--Kathy Newman, RN, BSN

Check out these tips for exercising when you have cancer. 

Latest Cancer News
Avastin® Linked with Increased Risk of Blood Clots

November 20, 2008 — According to a combined analysis of previously published studies, cancer patients who use Avastin® (bevacizumab) may have an increased risk of venous thromboembolism (a blood clot in a vein). These results were published in the Journal of the American Medical Association.

Addition of Avastin® to Paraplatin®, Taxol®, and Erbitux® Promising for Advanced NSCLC

November 20, 2008 — Researchers affiliated with the Southwest Oncology Group have reported that the four-drug combination of chemotherapy agents Paraplatin® (carboplatin) and Taxol® (paclitaxel) plus targeted therapies Avastin® (bevacizumab) and Erbitux® (cetuximab) is safe and may improve survival in patients with advanced non–small cell lung cancer (NSCLC). The details of this study were presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology November 13-15.

Avastin® Increases Risk of Venous Thromboembolism

November 20, 2008 — Researchers from Stony Brook University have reported that the use of Avastin® (bevacizumab) increases the risk of thromboembolism. The details of this review were published in the November 19, 2008 issue of the Journal of the American Medical Association.

Select news items provided by Reuters Health